315 related articles for article (PubMed ID: 31521479)
1. Outcomes of heart transplantation from hepatitis C virus-positive donors.
Aslam S; Yumul I; Mariski M; Pretorius V; Adler E
J Heart Lung Transplant; 2019 Dec; 38(12):1259-1267. PubMed ID: 31521479
[TBL] [Abstract][Full Text] [Related]
2. Using HCV-viremic organs for lung transplantation does not confer higher rejection rates compared to HCV-negative organs.
Afshar K; Schonhoft E; Kozuch J; Kafi A; Yung G; Pollema T; Golts E; Aslam S
Clin Transplant; 2024 Feb; 38(2):e15260. PubMed ID: 38369851
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C-positive donor to negative recipient kidney transplantation: A real-world experience.
Jandovitz N; Nair V; Grodstein E; Molmenti E; Fahmy A; Abate M; Bhaskaran M; Teperman L
Transpl Infect Dis; 2021 Jun; 23(3):e13540. PubMed ID: 33259125
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
[TBL] [Abstract][Full Text] [Related]
5. Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients.
Aqel B; Wijarnpreecha K; Pungpapong S; Taner CB; Reddy K; Leise M; Mi L; Dickson RC
J Hepatol; 2021 Apr; 74(4):873-880. PubMed ID: 33188903
[TBL] [Abstract][Full Text] [Related]
6. Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.
Friebus-Kardash J; Gäckler A; Kribben A; Witzke O; Wedemeyer H; Treckmann J; Herzer K; Eisenberger U
Transpl Infect Dis; 2019 Oct; 21(5):e13146. PubMed ID: 31306562
[TBL] [Abstract][Full Text] [Related]
7. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.
Kwong AJ; Wall A; Melcher M; Wang U; Ahmed A; Subramanian A; Kwo PY
Am J Transplant; 2019 May; 19(5):1380-1387. PubMed ID: 30378723
[TBL] [Abstract][Full Text] [Related]
9. Impact of Early Initiation of Direct-Acting Antiviral Therapy in Thoracic Organ Transplantation From Hepatitis C Virus Positive Donors.
Smith DE; Chen S; Fargnoli A; Lewis T; Galloway AC; Kon ZN; Moazami N
Semin Thorac Cardiovasc Surg; 2021; 33(2):407-415. PubMed ID: 32621962
[TBL] [Abstract][Full Text] [Related]
10. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors.
Reyentovich A; Gidea CG; Smith D; Lonze B; Kon Z; Fargnoli A; Pavone J; Rao S; Saraon T; Lewis T; Qian Y; Jacobson I; Moazami N
Clin Transplant; 2020 Sep; 34(9):e13989. PubMed ID: 32441413
[TBL] [Abstract][Full Text] [Related]
12. Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.
Bethea ED; Gaj K; Gustafson JL; Axtell A; Lebeis T; Schoenike M; Turvey K; Coglianese E; Thomas S; Newton-Cheh C; Ibrahim N; Carlson W; Ho JE; Shah R; Nayor M; Gift T; Shao S; Dugal A; Markmann J; Elias N; Yeh H; Andersson K; Pratt D; Bhan I; Safa K; Fishman J; Kotton C; Myoung P; Villavicencio MA; D'Alessandro D; Chung RT; Lewis GD
Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):771-780. PubMed ID: 31353243
[TBL] [Abstract][Full Text] [Related]
13. Cardiac transplantation from non-viremic hepatitis C donors.
Patel SR; Madan S; Saeed O; Sims DB; Shin JJ; Nucci C; Borukhov E; Goldstein DY; Jakobleff W; Forest S; Vukelic S; Murthy S; Reinus J; Puius Y; Goldstein DJ; Jorde UP
J Heart Lung Transplant; 2018 Oct; 37(10):1254-1260. PubMed ID: 30126825
[TBL] [Abstract][Full Text] [Related]
14. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
Czarnecka P; Czarnecka K; Tronina O; Baczkowska T; Durlik M
Ren Fail; 2022 Dec; 44(1):434-449. PubMed ID: 35260039
[TBL] [Abstract][Full Text] [Related]
15. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
[TBL] [Abstract][Full Text] [Related]
16. Expanding the Deceased Donor Pool in Manitoba Using Hepatitis C-Viremic Donors: Program Report.
Cuvelier S; Van Caeseele P; Kadatz M; Peterson K; Sun S; Dodd N; Werestiuk K; Koulack J; Nickerson P; Ho J
Can J Kidney Health Dis; 2021; 8():20543581211033496. PubMed ID: 34367648
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.
de Vera ME; Volk ML; Ncube Z; Blais S; Robinson M; Allen N; Evans R; Weissman J; Baron P; Kore A; Bratton C; Garnett G; Hoang T; Wai P; Villicana R
Am J Transplant; 2018 Oct; 18(10):2451-2456. PubMed ID: 30040178
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
[TBL] [Abstract][Full Text] [Related]
19. Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.
Madan S; Patel SR; Rahgozar K; Saeed O; Murthy S; Vukelic S; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
J Heart Lung Transplant; 2019 Sep; 38(9):907-917. PubMed ID: 31495408
[TBL] [Abstract][Full Text] [Related]
20. Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies.
Schlendorf KH; Zalawadiya S; Shah AS; Wigger M; Chung CY; Smith S; Danter M; Choi CW; Keebler ME; Brinkley DM; Sacks SB; Ooi H; Perri R; Awad JA; Lewis S; Hayes R; O'Dell H; Darragh C; Carver A; Edmonds C; Ruzevich-Scholl S; Lindenfeld J
J Heart Lung Transplant; 2018 Jun; 37(6):763-769. PubMed ID: 29530322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
